Description
Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses | HTML | Open resource | |
| Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses | HTML | Open resource |